Earli
Make Cancer A Benign Experience
- Headquarters
- Redwood City, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- earli.com
- Total Funding
- $40.0M
- Last Round
- $40.0M Series AJan 2021
- Rounds
- 1
About
Earli is a biotechnology company developing programmable genetic constructs that selectively activate inside cancer cells, reprogramming them to produce their own therapies and destroy themselves. Founded in June 2018 by Cyriac Roeding, David Suhy, and Sanjiv Gambhir at Johnson & Johnson JLABS in South San Francisco, the company is pioneering a synthetic biology approach to early cancer detection and treatment. Earli is backed by prominent investors including Andreessen Horowitz and Khosla Ventures and is headquartered in Redwood City, California.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jan 2021
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biopharmaceutical services company